PDF herunterladen
Semin intervent Radiol 2017; 34(04): 313-321
DOI: 10.1055/s-0037-1608826
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Incorporating Quality of Life Metrics in Interventional Oncology Practice

David Li
1   Department of Radiology, Division of Interventional Radiology, New York Presbyterian Hospital/Weill Cornell Medical Center, New York, New York
,
David C. Madoff
1   Department of Radiology, Division of Interventional Radiology, New York Presbyterian Hospital/Weill Cornell Medical Center, New York, New York
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
14. Dezember 2017 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Abstract

Interventional radiologists care for a large number of cancer patients with the breadth of palliative intent minimally invasive procedures that we provide. Understanding our meaningful impact on patients' quality of life is essential toward validating our role in the palliation of cancer patients. As such, it is critically important for interventional radiologists to understand common instruments used for the reporting of patient's quality of life measures. Common instruments used to measure pain and quality of life for cancer patients include the numerical rating scale, visual analog scale, brief pain inventory, the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire, and the Functional Assessment of Cancer Therapy. An ideal quality of life instrument should be a patient reported outcome measure across multiple domains (e.g., physical health, psychological, social), and be both validated and reliable.

Keywords

palliative care - interventional radiology - quality of life - visual analog scale - numeric rating scale - brief pain inventory - EORTC-30 - FACT-G
 

  • References

  • 1 Bakitas MA, Tosteson TD, Li Z. , et al. Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the ENABLE III Randomized Controlled Trial. J Clin Oncol 2015; 33 (13) 1438-1445
    CrossrefPubMedGoogle Scholar
  • 2 Smith TJ, Temin S, Alesi ER. , et al. American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol 2012; 30 (08) 880-887
    CrossrefPubMedGoogle Scholar
  • 3 Temel JS, Greer JA, Muzikansky A. , et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 2010; 363 (08) 733-742
    CrossrefPubMedGoogle Scholar
  • 4 Yoong J, Park ER, Greer JA. , et al. Early palliative care in advanced lung cancer: a qualitative study. JAMA Intern Med 2013; 173 (04) 283-290
    CrossrefPubMedGoogle Scholar
  • 5 Zimmermann C, Swami N, Krzyzanowska M. , et al. Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet 2014; 383 (9930): 1721-1730
    CrossrefPubMedGoogle Scholar
  • 6 Franklin JM, Gebski V, Poston GJ, Sharma RA. Clinical trials of interventional oncology-moving from efficacy to outcomes. Nat Rev Clin Oncol 2015; 12 (02) 93-104
    CrossrefPubMedGoogle Scholar
  • 7 Kaufman JA, Reekers JA, Burnes JP. , et al. Global statement defining interventional radiology. J Vasc Interv Radiol 2010; 21 (08) 1147-1149
    CrossrefPubMedGoogle Scholar
  • 8 Fairchild AH, Rilling WS. Palliative interventional oncology. Cancer J 2016; 22 (06) 411-417
    CrossrefPubMedGoogle Scholar
  • 9 Li D, Hussaini S, Kang J, Madoff DC. The role of interventional oncology in the palliative care of cancer patients. Expert Rev Qual Life Cancer Care 2016; 1: 73-87
    PubMedGoogle Scholar
  • 10 Ferrell BR, Wisdom C, Wenzl C. Quality of life as an outcome variable in the management of cancer pain. Cancer 1989; 63 (11, Suppl): 2321-2327
    CrossrefPubMedGoogle Scholar
  • 11 Tchekmedyian NS, Hickman M, Siau J, Greco A, Aisner J. Treatment of cancer anorexia with megestrol acetate: impact on quality of life. Oncology (Williston Park) 1990; 4 (05) 185-192 , discussion 194
    PubMedGoogle Scholar
  • 12 Olschewski M, Schulgen G, Schumacher M, Altman DG. Quality of life assessment in clinical cancer research. Br J Cancer 1994; 70 (01) 1-5
    CrossrefPubMedGoogle Scholar
  • 13 Aitken RC. Measurement of feelings using visual analogue scales. Proc R Soc Med 1969; 62 (10) 989-993
    PubMedGoogle Scholar
  • 14 Wong DL, Baker CM. Pain in children: comparison of assessment scales. Pediatr Nurs 1988; 14 (01) 9-17
    Google Scholar
  • 15 Daut RL, Cleeland CS, Flanery RC. Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain 1983; 17 (02) 197-210
    CrossrefPubMedGoogle Scholar
  • 16 EORTC QLQ-C30. Accessed at: http://groups.eortc.be/qol/eortc-qlq-c30 . Accessed November 7, 2017
    PubMed
  • 17 Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore 1994; 23 (02) 129-138
    PubMedGoogle Scholar
  • 18 Callstrom MR, Dupuy DE, Solomon SB. , et al. Percutaneous image-guided cryoablation of painful metastases involving bone: multicenter trial. Cancer 2013; 119 (05) 1033-1041
    CrossrefPubMedGoogle Scholar
  • 19 Callstrom MR, Atwell TD, Charboneau JW. , et al. Painful metastases involving bone: percutaneous image-guided cryoablation--prospective trial interim analysis. Radiology 2006; 241 (02) 572-580
    CrossrefPubMedGoogle Scholar
  • 20 Goetz MP, Callstrom MR, Charboneau JW. , et al. Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study. J Clin Oncol 2004; 22 (02) 300-306
    CrossrefPubMedGoogle Scholar
  • 21 Callstrom MR, Charboneau JW, Goetz MP. , et al. Painful metastases involving bone: feasibility of percutaneous CT- and US-guided radio-frequency ablation. Radiology 2002; 224 (01) 87-97
    CrossrefPubMedGoogle Scholar
  • 22 Hartsell WF, Scott CB, Bruner DW. , et al. Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst 2005; 97 (11) 798-804
    CrossrefPubMedGoogle Scholar
  • 23 Aaronson NK, Ahmedzai S, Bergman B. , et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85 (05) 365-376
    CrossrefPubMedGoogle Scholar
  • 24 Sprangers MA, Cull A, Bjordal K, Groenvold M, Aaronson NK. ; EORTC Study Group on Quality of Life. The European Organization for Research and Treatment of Cancer. Approach to quality of life assessment: guidelines for developing questionnaire modules. Qual Life Res 1993; 2 (04) 287-295
    CrossrefPubMedGoogle Scholar
  • 25 Sprangers MA, Cull A, Groenvold M, Bjordal K, Blazeby J, Aaronson NK. ; EORTC Quality of Life Study Group. The European Organization for Research and Treatment of Cancer approach to developing questionnaire modules: an update and overview. Qual Life Res 1998; 7 (04) 291-300
    CrossrefPubMedGoogle Scholar
  • 26 Schaafsma J, Osoba D. The Karnofsky Performance Status Scale re-examined: a cross-validation with the EORTC-C30. Qual Life Res 1994; 3 (06) 413-424
    CrossrefPubMedGoogle Scholar
  • 27 Cella DF, Tulsky DS, Gray G. , et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 1993; 11 (03) 570-579
    CrossrefPubMedGoogle Scholar
  • 28 Sato K, Shimizu M, Miyashita M. Which quality of life instruments are preferred by cancer patients in Japan? Comparison of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30 and the Functional Assessment of Cancer Therapy-General. Support Care Cancer 2014; 22 (12) 3135-3141
    CrossrefPubMedGoogle Scholar
  • 29 Smith AB, Cocks K, Parry D, Taylor M. Reporting of health-related quality of life (HRQOL) data in oncology trials: a comparison of the European Organization for Research and Treatment of Cancer Quality of Life (EORTC QLQ-C30) and the Functional Assessment of Cancer Therapy-General (FACT-G). Qual Life Res 2014; 23 (03) 971-976
    CrossrefPubMedGoogle Scholar
  • 30 Luckett T, King MT, Butow PN. , et al. Choosing between the EORTC QLQ-C30 and FACT-G for measuring health-related quality of life in cancer clinical research: issues, evidence and recommendations. Ann Oncol 2011; 22 (10) 2179-2190
    CrossrefPubMedGoogle Scholar
  • 31 Cheung YB, Goh C, Thumboo J, Khoo KS, Wee J. Quality of life scores differed according to mode of administration in a review of three major oncology questionnaires. J Clin Epidemiol 2006; 59 (02) 185-191
    CrossrefPubMedGoogle Scholar
  • 32 Cheung YB, Goh C, Thumboo J, Khoo KS, Wee J. Variability and sample size requirements of quality-of-life measures: a randomized study of three major questionnaires. J Clin Oncol 2005; 23 (22) 4936-4944
    CrossrefPubMedGoogle Scholar
  • 33 Holzner B, Bode RK, Hahn EA. , et al. Equating EORTC QLQ-C30 and FACT-G scores and its use in oncological research. Eur J Cancer 2006; 42 (18) 3169-3177
    CrossrefPubMedGoogle Scholar
  • 34 Monsky WL, Khorsand D, Nolan T, Douglas D, Khanna P. Quality of life assessment in interventional radiology. Acad Radiol 2014; 21 (03) 407-414
    CrossrefPubMedGoogle Scholar
  • 35 Arai Y. Clinical trials of interventional oncology. Int J Clin Oncol 2012; 17 (04) 301-305
    CrossrefPubMedGoogle Scholar
  • 36 Lungren MP, Kim CY, Stewart JK, Smith TP, Miller MJ. Tunneled peritoneal drainage catheter placement for refractory ascites: single-center experience in 188 patients. J Vasc Interv Radiol 2013; 24 (09) 1303-1308
    CrossrefPubMedGoogle Scholar
  • 37 Maleux G, Indesteege I, Laenen A, Verslype C, Vergote I, Prenen H. Tenckhoff tunneled peritoneal catheter placement in the palliative treatment of malignant ascites: technical results and overall clinical outcome. Radiol Oncol 2016; 50 (02) 197-203
    CrossrefPubMedGoogle Scholar
  • 38 Monsky WL, Yoneda KY, MacMillan J. , et al. Peritoneal and pleural ports for management of refractory ascites and pleural effusions: assessment of impact on patient quality of life and hospice/home nursing care. J Palliat Med 2009; 12 (09) 811-817
    CrossrefPubMedGoogle Scholar
  • 39 Benson III AB, Abrams TA, Ben-Josef E. , et al. NCCN clinical practice guidelines in oncology: hepatobiliary cancers. J Natl Compr Canc Netw 2009; 7 (04) 350-391
    CrossrefPubMedGoogle Scholar
  • 40 Benson III AB, Bekaii-Saab T, Chan E. , et al. Metastatic colon cancer, version 3.2013: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw 2013; 11 (02) 141-152 , quiz 152
    CrossrefPubMedGoogle Scholar
  • 41 Benson III AB, Venook AP, Cederquist L. , et al. Colon cancer, version 1.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 2017; 15 (03) 370-398
    CrossrefPubMedGoogle Scholar
  • 42 Llovet JM, Zucman-Rossi J, Pikarsky E. , et al. Hepatocellular carcinoma. Nat Rev Dis Primers 2016; 2: 16018
    CrossrefPubMedGoogle Scholar
  • 43 Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999; 19 (03) 329-338
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 44 Ahmed S, de Souza NN, Qiao W, Kasai M, Keem LJ, Shelat VG. Quality of life in hepatocellular carcinoma patients treated with transarterial chemoembolization. HPB Surg 2016; 2016: 6120143
    CrossrefPubMedGoogle Scholar
  • 45 Xing M, Webber G, Prajapati HJ. , et al. Preservation of quality of life with doxorubicin drug-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma: longitudinal prospective study. J Gastroenterol Hepatol 2015; 30 (07) 1167-1174
    CrossrefPubMedGoogle Scholar
  • 46 Wible BC, Rilling WS, Drescher P. , et al. Longitudinal quality of life assessment of patients with hepatocellular carcinoma after primary transarterial chemoembolization. J Vasc Interv Radiol 2010; 21 (07) 1024-1030
    CrossrefPubMedGoogle Scholar
  • 47 Shun SC, Chen CH, Sheu JC, Liang JD, Yang JC, Lai YH. Quality of life and its associated factors in patients with hepatocellular carcinoma receiving one course of transarterial chemoembolization treatment: a longitudinal study. Oncologist 2012; 17 (05) 732-739
    CrossrefPubMedGoogle Scholar
  • 48 Salem R, Gilbertsen M, Butt Z. , et al. Increased quality of life among hepatocellular carcinoma patients treated with radioembolization, compared with chemoembolization. Clin Gastroenterol Hepatol 2013; 11 (10) 1358-1365.e1
    CrossrefPubMedGoogle Scholar
  • 49 Huang G, Chen X, Lau WY. , et al. Quality of life after surgical resection compared with radiofrequency ablation for small hepatocellular carcinomas. Br J Surg 2014; 101 (08) 1006-1015
    CrossrefPubMedGoogle Scholar
  • 50 Toro A, Pulvirenti E, Palermo F, Di Carlo I. Health-related quality of life in patients with hepatocellular carcinoma after hepatic resection, transcatheter arterial chemoembolization, radiofrequency ablation or no treatment. Surg Oncol 2012; 21 (01) e23-e30
    CrossrefPubMedGoogle Scholar